Cyclerion Therapeutics, Inc.·4

Jun 28, 5:22 PM ET

Isacson Ole 4

4 · Cyclerion Therapeutics, Inc. · Filed Jun 28, 2021

Insider Transaction Report

Form 4
Period: 2021-06-24
Isacson Ole
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-24+10,00010,000 total
    Exercise: $3.97Exp: 2031-06-24Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]. The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date

Documents

2 files